A clear message is needed here: Find another investigator.
The Sponsor of an IND study should not engage an investigator who declares their unwillingness to sign a Form FDA-1572, and certainly should not allow either initial or continuing participation of an investigator/site that may have been signed up with the Sponsor but then refuses to complete this necessary attestation. This is a clear requirement in the IND regulations at 21 CFR 312.53(c)(1), where the message is "...
the sponsor shall obtain...(1) A signed investigator statement (Form FDA-1572)...," - emphasis on "shall." Yes, there are instances where use of the Form FDA-1572 itself could be accomplished by another document, particularly for non-US sites who argue the US form format is possibly not legally binding in their country, but that means little as GCP has virtually identical requirements that must be attested to in a written investigator agreement with the Sponsor. In that case, aligning the text exactly may be the best option. The IND regulation includes a list of specific details that are critical for assigning/accepting responsibilities of an investigator, as outlined on the form and copied from the regulation. It's pretty straight forward from a regulatory standpoint. Not agreeing to those conditions means the investigator is not qualified, if not really interested, and Sponsors must, among other requirements, select qualified investigators.
Any Sponsor who decides to proceed anyway, not only risks having the FDA invalidate data submitted from that site-yes, this really happens- but will spend perhaps significant monetary and time costs in dealing with this for little useful outcome.
I repeat: Find another investigator.
Best regards,
------------------------------
Jan S. Peterson, MS, CCRA, RAC, ASQ CBA, ACRP-CP
Consultant
United States
------------------------------
Original Message:
Sent: 23-Jan-2023 18:19
From: Anonymous Member
Subject: 1572 Sites Refuse to sign 1572
This message was posted by a user wishing to remain anonymous
I have a question about sites that refuse to sign a 1572 or equivalent document. For IND studies, what are the implications of including the site in the study and would the FDA accept the data from these sites?
Thank you in advance!